NCT04566367

Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer

Detection Rate by Blue Laser Imaging (BLI) of Secondary or Early Squamous Head and Neck Cancer in Patients Undergoing Elective Percutaneous Endoscopic Gastrostomy (PEG)

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 140 (estimated)
• Sponsor: Georg Dultz · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study wants to focus on Carcinoma detection rates with blue laser imaging (BLI) for participants with head-neck cancer who need a percutaneous endoscopic gastrostomy (PEG). BLI is a new imaging technique that can easily be used within a standard gastroscopy.

Detailed description

Head-Neck cancers are a significant burden all around the world. Patients suffering from one tumor are at high risk for a second cancer or another precancerous lesion. Before or during cancer treatment a PEG is needed to maintain a sufficient calories intake. PEG is established by performing a standard gastroscopy. This randomised study wants to compare the detection rates of standard white light endoscopy compared to the additional use of blue laser imaging for second cancers or precancerous lesions in participants presenting for PEG establishment.

Conditions

• Head Neck Cancer
• Esophageal Cancer
• Gastrostomy

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	blue laser imaging	The intervention is the push on demand activation of blue laser imaging technique during gastroscopy.

Timeline

• Start date: 2020-09-22
• Primary completion: 2023-02-02
• Completion: 2024-08-31
• First posted: 2020-09-28
• Last updated: 2023-07-13

Locations

1 site across 1 country: Germany